Drugs / AR9281
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00847899 Comparator | Jan → Oct 2009 | glucose intolerance, hypertensive disorder | Arete Therapeutics | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AR9281 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00847899 ↗ |
| Action | Inhibit | “Epoxide hydratase inhibitor” CHEMBL436774 ↗1“s-EH enzyme inhibitor” NCT00847899 ↗ |
| Modality | Small molecule | — CHEMBL436774 ↗ |
| Target | EPHX2 | “Epoxide hydratase inhibitor” CHEMBL436774 ↗ |